13 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Article Searches
Eni (E) Boosts UK CCS Leadership With CCUS Market Launch https://www.zacks.com/stock/news/2201565/eni-e-boosts-uk-ccs-leadership-with-ccus-market-launch?cid=CS-ZC-FT-analyst_blog|company_news_-_energy_sector-2201565 Dec 22, 2023 - Eni (E) plays a significant role in the expansion of the HyNet Cluster, operating CO2 transport and storage within this initiative.
Cidara (CDTX) Up on EC Nod for Rezzayo in Invasive Candidiasis https://www.zacks.com/stock/news/2202251/cidara-cdtx-up-on-ec-nod-for-rezzayo-in-invasive-candidiasis?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2202251 Dec 26, 2023 - Cidara's (CDTX) Rezzayo (rezafungin acetate) gets approval from the European Commission for the treatment of invasive candidiasis in adults. The stock rises 11.1%.
Why Investors Need to Take Advantage of These 2 Oils and Energy Stocks Now https://www.zacks.com/stock/news/2202122/why-investors-need-to-take-advantage-of-these-2-oils-and-energy-stocks-now?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_earnings_esp-2202122 Dec 26, 2023 - The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

Pages: 12

<Page 2